Linagliptin as Add on to Basal Insulin in the Elderly

NCT02240680 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: placebo
DRUG: linagliptin

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]